VANCOUVER, British Columbia--(BUSINESS WIRE)--May 30, 2006--HepaLife Technologies, Inc. (OTCBB: HPLF - News; FWB: HL1): HepaLife’s liver cells demonstrate ability to function and survive without feeder cell support, following successful room temperature and human plasma survival outcomes; findings crucial to artificial liver device.
